147 related articles for article (PubMed ID: 20038960)
21. Clinical and dosimetric predictors of late rectal toxicity after conformal radiation for localized prostate cancer: results of a large multicenter observational study.
Fellin G; Fiorino C; Rancati T; Vavassori V; Baccolini M; Bianchi C; Cagna E; Gabriele P; Mauro F; Menegotti L; Monti AF; Stasi M; Valdagni R
Radiother Oncol; 2009 Nov; 93(2):197-202. PubMed ID: 19828205
[TBL] [Abstract][Full Text] [Related]
22. Pilot study of conformal intensity modulated radiation therapy for localized prostate cancer.
Aillères N; Azria D; Thézenas S; Barbier N; Fenoglietto P; Delard R; Hay MH; Dubois JB
Cancer Radiother; 2004 Apr; 8(2):59-69. PubMed ID: 15063872
[TBL] [Abstract][Full Text] [Related]
23. Intensity-modulated radiotherapy as primary treatment for prostate cancer: acute toxicity in 114 patients.
De Meerleer G; Vakaet L; Meersschout S; Villeirs G; Verbaeys A; Oosterlinck W; De Neve W
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):777-87. PubMed ID: 15465194
[TBL] [Abstract][Full Text] [Related]
24. Predictors for rectal and intestinal acute toxicities during prostate cancer high-dose 3D-CRT: results of a prospective multicenter study.
Vavassori V; Fiorino C; Rancati T; Magli A; Fellin G; Baccolini M; Bianchi C; Cagna E; Mauro FA; Monti AF; Munoz F; Stasi M; Franzone P; Valdagni R
Int J Radiat Oncol Biol Phys; 2007 Apr; 67(5):1401-10. PubMed ID: 17241754
[TBL] [Abstract][Full Text] [Related]
25. Rectal bleeding, fecal incontinence, and high stool frequency after conformal radiotherapy for prostate cancer: normal tissue complication probability modeling.
Peeters ST; Hoogeman MS; Heemsbergen WD; Hart AA; Koper PC; Lebesque JV
Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):11-9. PubMed ID: 16757129
[TBL] [Abstract][Full Text] [Related]
26. Hypofractionated intensity-modulated radiotherapy (70 gy at 2.5 Gy per fraction) for localized prostate cancer: long-term outcomes.
Kupelian PA; Thakkar VV; Khuntia D; Reddy CA; Klein EA; Mahadevan A
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1463-8. PubMed ID: 16169683
[TBL] [Abstract][Full Text] [Related]
27. Late gastrointestinal morbidity after three-dimensional conformal radiation therapy for prostate cancer fades with time in contrast to genitourinary morbidity.
Karlsdóttir A; Muren LP; Wentzel-Larsen T; Dahl O
Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1478-86. PubMed ID: 18060703
[TBL] [Abstract][Full Text] [Related]
28. Comparison of rectal dose-wall histogram versus dose-volume histogram for modeling the incidence of late rectal bleeding after radiotherapy.
Tucker SL; Dong L; Cheung R; Johnson J; Mohan R; Huang EH; Liu HH; Thames HD; Kuban D
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1589-601. PubMed ID: 15590191
[TBL] [Abstract][Full Text] [Related]
29. Patient-assessed late toxicity rates and principal component analysis after image-guided radiation therapy for prostate cancer.
Skala M; Rosewall T; Dawson L; Divanbeigi L; Lockwood G; Thomas C; Crook J; Chung P; Warde P; Catton C
Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):690-8. PubMed ID: 17379434
[TBL] [Abstract][Full Text] [Related]
30. Does treatment of the pelvic nodes with IMRT increase late rectal toxicity over conformal prostate-only radiotherapy to 76 Gy?
Sanguineti G; Cavey ML; Endres EJ; Franzone P; Barra S; Parker BC; Marcenaro M; Colman M; Agostinelli S; Foppiano F; Vitale V
Strahlenther Onkol; 2006 Sep; 182(9):543-9. PubMed ID: 16944377
[TBL] [Abstract][Full Text] [Related]
31. Dynamic conformal arc radiotherapy with rectum hollow-out technique for localized prostate cancer.
Tomita N; Kodaira T; Tachibana H; Nakamura T; Tomoda T; Nakahara R; Inokuchi H; Hayashi N; Fuwa N
Radiother Oncol; 2009 Mar; 90(3):346-52. PubMed ID: 18950880
[TBL] [Abstract][Full Text] [Related]
32. Rectal wall sparing by dosimetric effect of rectal balloon used during intensity-modulated radiation therapy (IMRT) for prostate cancer.
Teh BS; Dong L; McGary JE; Mai WY; Grant W; Butler EB
Med Dosim; 2005; 30(1):25-30. PubMed ID: 15749008
[TBL] [Abstract][Full Text] [Related]
33. Dosimetric impact and theoretical clinical benefits of fiducial markers for dose escalated prostate cancer radiation treatment.
Gauthier I; Carrier JF; Béliveau-Nadeau D; Fortin B; Taussky D
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1128-33. PubMed ID: 19147306
[TBL] [Abstract][Full Text] [Related]
34. Acute morbidity related to treatment volume during 3D-conformal radiation therapy for prostate cancer.
Karlsdóttir A; Johannessen DC; Muren LP; Wentzel-Larsen T; Dahl O
Radiother Oncol; 2004 Apr; 71(1):43-53. PubMed ID: 15066295
[TBL] [Abstract][Full Text] [Related]
35. Impact of volume and location of irradiated rectum wall on rectal blood loss after radiotherapy of prostate cancer.
Koper PC; Heemsbergen WD; Hoogeman MS; Jansen PP; Hart GA; Wijnmaalen AJ; van Os M; Boersma LJ; Lebesque JV; Levendag P
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1072-82. PubMed ID: 15001247
[TBL] [Abstract][Full Text] [Related]
36. Stereotactic body radiotherapy for localized prostate cancer: interim results of a prospective phase II clinical trial.
King CR; Brooks JD; Gill H; Pawlicki T; Cotrutz C; Presti JC
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1043-8. PubMed ID: 18755555
[TBL] [Abstract][Full Text] [Related]
37. 3-D conformal radiotherapy of localized prostate cancer: a subgroup analysis of rectoscopic findings prior to radiotherapy and acute/late rectal side effects.
Goldner G; Zimmermann F; Feldmann H; Glocker S; Wachter-Gerstner N; Geinitz H; Becker G; Pötzi R; Wambersie A; Bamberg M; Molls M; Wachter S; Pötter R
Radiother Oncol; 2006 Jan; 78(1):36-40. PubMed ID: 16271410
[TBL] [Abstract][Full Text] [Related]
38. Long-term outcome of high dose intensity modulated radiation therapy for patients with clinically localized prostate cancer.
Zelefsky MJ; Chan H; Hunt M; Yamada Y; Shippy AM; Amols H
J Urol; 2006 Oct; 176(4 Pt 1):1415-9. PubMed ID: 16952647
[TBL] [Abstract][Full Text] [Related]
39. Fitting late rectal bleeding data using different NTCP models: results from an Italian multi-centric study (AIROPROS0101).
Rancati T; Fiorino C; Gagliardi G; Cattaneo GM; Sanguineti G; Borca VC; Cozzarini C; Fellin G; Foppiano F; Girelli G; Menegotti L; Piazzolla A; Vavassori V; Valdagni R
Radiother Oncol; 2004 Oct; 73(1):21-32. PubMed ID: 15465142
[TBL] [Abstract][Full Text] [Related]
40. Late rectal symptoms and quality of life after conformal radiation therapy for prostate cancer.
Geinitz H; Zimmermann FB; Thamm R; Erber C; Müller T; Keller M; Busch R; Molls M
Radiother Oncol; 2006 Jun; 79(3):341-7. PubMed ID: 16733072
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
